XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 25.87

+1.3%

3:40 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: aknahow who wrote (15910)	7/21/2002 11:58:08 PM
From: Cacaito	Read Replies (2) of 17367

Just a reminder: Rituxan is already a $1 billion, and expected to hit $2 billion in 2 years. 2% of $1 billion is $20 millions/70 million shares = $0.28 per share ! 2% of $2B is $40M/100 million shares (adjusting for 2 to 3 years of extra issues) = $0.40 per share! All given away for $17Miserly millions to pump into a stupid trauma pIII trial. Idiocy ? Dishonesty? Who is behind the royalties buying company?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next